These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse. Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720 [TBL] [Abstract][Full Text] [Related]
5. Influence of the Bone Marrow Microenvironment on Hematopoietic Stem Cell Behavior Post-Allogeneic Transplantation: Development of Clonal Hematopoiesis and Telomere Dynamics. Kim M; Kang D; Kim HS; Lee JM; Park S; Kwag D; Lee C; Hong Y; Na D; Koh Y; Sun CH; An H; Kim YJ; Kim Y Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408588 [TBL] [Abstract][Full Text] [Related]
6. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation. Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200 [TBL] [Abstract][Full Text] [Related]
7. Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation. Williams LS; Williams KM; Gillis N; Bolton K; Damm F; Deuitch NT; Farhadfar N; Gergis U; Keel SB; Michelis FV; Panch SR; Porter CC; Sucheston-Campbell L; Tamari R; Stefanski HE; Godley LA; Lai C Transplant Cell Ther; 2024 Mar; 30(3):255-267. PubMed ID: 37913908 [TBL] [Abstract][Full Text] [Related]
8. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation. Frick M; Chan W; Arends CM; Hablesreiter R; Halik A; Heuser M; Michonneau D; Blau O; Hoyer K; Christen F; Galan-Sousa J; Noerenberg D; Wais V; Stadler M; Yoshida K; Schetelig J; Schuler E; Thol F; Clappier E; Christopeit M; Ayuk F; Bornhäuser M; Blau IW; Ogawa S; Zemojtel T; Gerbitz A; Wagner EM; Spriewald BM; Schrezenmeier H; Kuchenbauer F; Kobbe G; Wiesneth M; Koldehoff M; Socié G; Kroeger N; Bullinger L; Thiede C; Damm F J Clin Oncol; 2019 Feb; 37(5):375-385. PubMed ID: 30403573 [TBL] [Abstract][Full Text] [Related]
9. Clonal Hematopoiesis-Associated Gene Mutations Affect Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation in AML Patients. Wei X; Huang S; Gu Z; Liu J; Li M; Jin X; Bo J; Li F; Jing Y; Gao X; Dou L; Liu D; Gao C Ann Transplant; 2024 Jul; 29():e943688. PubMed ID: 38952007 [TBL] [Abstract][Full Text] [Related]
10. Clonal hematopoiesis in the setting of hematopoietic cell transplantation. Gibson CJ; Lindsley RC; Gondek LP Semin Hematol; 2024 Feb; 61(1):9-15. PubMed ID: 38429201 [TBL] [Abstract][Full Text] [Related]
11. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation. Oran B; Champlin RE; Wang F; Tanaka T; Saliba RM; Al-Atrash G; Garcia-Manero G; Kantarjian H; Cao K; Shpall EJ; Alousi AM; Mehta RS; Popat U; Futreal A; Takahashi K Leukemia; 2022 Jan; 36(1):257-262. PubMed ID: 34135465 [TBL] [Abstract][Full Text] [Related]
12. Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysis. Xie Y; Kazakova V; Weeks LD; Gerber JM; Tai J; Zhang TY; Lowsky R; Wu X; Yang C; Patel SA Bone Marrow Transplant; 2024 Nov; 59(11):1585-1593. PubMed ID: 39183321 [TBL] [Abstract][Full Text] [Related]
13. [Relevance of clonal hematopoiesis for cellular therapies]. Teipel R; von Bonin M; Stölzel F; Schetelig J; Thiede C; Bornhäuser M Inn Med (Heidelb); 2022 Nov; 63(11):1126-1132. PubMed ID: 36149441 [TBL] [Abstract][Full Text] [Related]
14. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation. Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma. Lackraj T; Ben Barouch S; Medeiros JJF; Pedersen S; Danesh A; Bakhtiari M; Hong M; Tong K; Joynt J; Arruda A; Minden MD; Kuruvilla J; Bhella S; Kukreti V; Crump M; Prica A; Chen C; Deng Y; Xu W; Pugh TJ; Keating A; Dick JE; Abelson S; Kridel R Am J Hematol; 2022 Dec; 97(12):1538-1547. PubMed ID: 36087071 [TBL] [Abstract][Full Text] [Related]